PPT2
Basic information
Region (hg38): 6:32153441-32163678
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 0 |
Variants in PPT2
This is a list of pathogenic ClinVar variants found in the PPT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-32154634-G-A | not specified | Likely benign (Oct 13, 2023) | ||
6-32154686-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
6-32154743-A-G | not specified | Uncertain significance (May 17, 2023) | ||
6-32154758-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
6-32155030-A-T | not specified | Uncertain significance (Mar 24, 2023) | ||
6-32155045-G-C | not specified | Uncertain significance (Jun 03, 2022) | ||
6-32155141-G-A | not specified | Uncertain significance (Sep 26, 2024) | ||
6-32155151-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
6-32155180-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
6-32155693-C-A | not specified | Uncertain significance (Jun 02, 2023) | ||
6-32155909-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
6-32157648-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
6-32157860-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
6-32157917-C-G | not specified | Uncertain significance (Feb 17, 2022) | ||
6-32162807-G-A | not specified | Uncertain significance (Jul 25, 2024) | ||
6-32162817-G-C | not specified | Uncertain significance (Jun 12, 2023) | ||
6-32162873-A-G | not specified | Uncertain significance (May 16, 2023) | ||
6-32162909-C-G | not specified | Uncertain significance (Mar 28, 2024) | ||
6-32162931-T-C | not specified | Uncertain significance (Dec 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPT2 | protein_coding | protein_coding | ENST00000361568 | 9 | 12794 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00454 | 0.989 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.05 | 108 | 187 | 0.578 | 0.0000102 | 2000 |
Missense in Polyphen | 29 | 62.269 | 0.46572 | 687 | ||
Synonymous | 1.96 | 55 | 76.9 | 0.715 | 0.00000404 | 621 |
Loss of Function | 2.41 | 7 | 18.0 | 0.388 | 8.99e-7 | 183 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000952 | 0.0000906 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000535 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000988 | 0.0000980 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Removes thioester-linked fatty acyl groups from various substrates including S-palmitoyl-CoA. Has the highest S- thioesterase activity for the acyl groups palmitic and myristic acid followed by other short- and long-chain acyl substrates. However, because of structural constraints, is unable to remove palmitate from peptides or proteins. {ECO:0000269|PubMed:10417332, ECO:0000269|PubMed:12855696, ECO:0000269|PubMed:9341199}.;
- Pathway
- Lysosome - Homo sapiens (human);Fatty acid elongation - Homo sapiens (human);Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism;Fatty acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.106
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.06
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.496
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.862
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppt2
- Phenotype
- renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; cellular phenotype; muscle phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- fatty-acyl-CoA biosynthetic process;macromolecule depalmitoylation
- Cellular component
- lysosome;lysosomal lumen;extracellular exosome
- Molecular function
- palmitoyl-(protein) hydrolase activity;thiolester hydrolase activity;palmitoyl hydrolase activity